Evidence-based treatment of chronic immune-mediated neuropathies. - Université de Limoges Accéder directement au contenu
Article Dans Une Revue Expert Opinion on Pharmacotherapy Année : 2009

Evidence-based treatment of chronic immune-mediated neuropathies.


Immune-mediated neuropathies are treatable disorders that can result in considerable disability in some cases. Chronic immune-mediated neuropathies include chronic inflammatory demyelinating polyradiculoneuropathy, multifocal motor neuropathy and neuropathy associated with monoclonal gammopathy. In recent years, therapeutic strategies for these disorders have become clearer as a result of large, randomized controlled trials. However, the treatments used can have serious adverse effects and at least 30% of patients do not respond to conventional therapies. The aim of this paper is to review available data on evidence-based immunotherapy of chronic immune-mediated neuropathies and to summarize recent findings and results obtained with new innovative therapies, such as new immunosuppressants and monoclonal antibodies.
Fichier non déposé

Dates et versions

hal-00627974 , version 1 (30-09-2011)



Laurent Magy, Jean-Michel Vallat. Evidence-based treatment of chronic immune-mediated neuropathies.. Expert Opinion on Pharmacotherapy, 2009, 10 (11), pp.1741-54. ⟨10.1517/14656560903036095⟩. ⟨hal-00627974⟩
18 Consultations
0 Téléchargements



Gmail Facebook Twitter LinkedIn More